Novo Nordisk A/S
Zepbound copycats remain online despite FDA ban 2025
Zepbound Copycats Persist Online Despite FDA Ban March 21, 2025 — Despite a recent ban by the U.S. Food and Drug Administration (FDA) on ...
Eli Lilly to release weight loss pill orforglipron trial data
Eli Lilly to Unveil Trial Data for Oral Weight Loss Drug Orforglipron [City, Date] – Pharmaceutical giant Eli Lilly is set to release highly ...
Trump says pharmaceutical tariffs are coming, but stocks rise
Trump Indicators Pharmaceutical Tariffs Are Coming, But Shares Rise in Defiance April 9, 2025 – Washington, D.C. – President Donald Trump doubled down on ...
Novo Nordisk offers discounted Wegovy through direct-to-consumer pharmacy
Novo Nordisk’s Wegovy weight reduction drug has seen a meteoric rise in recognition. Novo Nordisk on Wednesday mentioned it’s going to provide its weight ...
Eli Lilly weight loss pill orforglipron clears first late-stage trial
Eli Lilly’s Orforglipron Clears First Late-Stage Trial, Boosts Weight Loss Hopes April 17, 2025 Indianapolis, IN – Eli Lilly’s experimental oral weight reduction tablet, ...
Amgen weight loss drug MariTide starts two phase three trials
The Amgen emblem is displayed exterior Amgen headquarters in Thousand Oaks, California, on Might 17, 2023. Amgen on Wednesday stated it has began two ...
Eli Lilly’s obesity pill will rival Novo Nordisk’s oral Wegovy drug
Eli Lilly’s Obesity Pill Orforglipron Challenges Novo Nordisk’s Oral Wegovy in Weight-Loss Market Race August 24, 2025 The obesity drug market, projected to surpass ...
Eli Lilly to build $5 billion Virginia manufacturing facility
Eli Lilly’s $5 Billion Bet on Virginia: A Game-Changer for U.S. Drug Manufacturing In a bold move to fortify America’s pharmaceutical backbone amid looming ...
